Ting-Lei Gu

6.3k total citations · 2 hit papers
12 papers, 2.1k citations indexed

About

Ting-Lei Gu is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Ting-Lei Gu has authored 12 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Hematology and 4 papers in Genetics. Recurrent topics in Ting-Lei Gu's work include Acute Myeloid Leukemia Research (5 papers), Fibroblast Growth Factor Research (3 papers) and Genomics and Chromatin Dynamics (3 papers). Ting-Lei Gu is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Fibroblast Growth Factor Research (3 papers) and Genomics and Chromatin Dynamics (3 papers). Ting-Lei Gu collaborates with scholars based in United States, Switzerland and Japan. Ting-Lei Gu's co-authors include Nancy A. Speck, Roberto D. Polakiewicz, Tamara L. Goetz, Barbara J. Graves, Sumin Kang, Sagar Lonial, Fadlo R. Khuri, Taro Hitosugi, Johannes Roesel and Titus J. Boggon and has published in prestigious journals such as Cell, Journal of Biological Chemistry and The EMBO Journal.

In The Last Decade

Ting-Lei Gu

12 papers receiving 2.1k citations

Hit Papers

Tyrosine Phosphorylation Inhibits PKM2 to Promote... 1996 2026 2006 2016 2009 1996 200 400 600

Peers

Ting-Lei Gu
Shannon Elf United States
Steven J. Freedman United States
Mark A. Gregory United States
Wen-Mei Yu United States
Kian Leong Lee Singapore
Ting‐Lei Gu United States
Silvia Grisendi United States
Ingrid J. Apel United States
Shannon Elf United States
Ting-Lei Gu
Citations per year, relative to Ting-Lei Gu Ting-Lei Gu (= 1×) peers Shannon Elf

Countries citing papers authored by Ting-Lei Gu

Since Specialization
Citations

This map shows the geographic impact of Ting-Lei Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ting-Lei Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ting-Lei Gu more than expected).

Fields of papers citing papers by Ting-Lei Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ting-Lei Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ting-Lei Gu. The network helps show where Ting-Lei Gu may publish in the future.

Co-authorship network of co-authors of Ting-Lei Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Ting-Lei Gu. A scholar is included among the top collaborators of Ting-Lei Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ting-Lei Gu. Ting-Lei Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Li, Dan, Lingtao Jin, Gina N. Alesi, et al.. (2013). The Prometastatic Ribosomal S6 Kinase 2-cAMP Response Element-binding Protein (RSK2-CREB) Signaling Pathway Up-regulates the Actin-binding Protein Fascin-1 to Promote Tumor Metastasis. Journal of Biological Chemistry. 288(45). 32528–32538. 44 indexed citations
2.
Hitosugi, Taro, Jun Fan, Tae‐Wook Chung, et al.. (2011). Tyrosine Phosphorylation of Mitochondrial Pyruvate Dehydrogenase Kinase 1 Is Important for Cancer Metabolism. Molecular Cell. 44(6). 864–877. 262 indexed citations
3.
Hitosugi, Taro, Sumin Kang, Matthew G. Vander Heiden, et al.. (2009). Tyrosine Phosphorylation Inhibits PKM2 to Promote the Warburg Effect and Tumor Growth. Science Signaling. 2(97). ra73–ra73. 618 indexed citations breakdown →
4.
Kang, Sumin, Shannon Elf, Shaozhong Dong, et al.. (2009). Fibroblast Growth Factor Receptor 3 Associates with and Tyrosine Phosphorylates p90 RSK2, Leading to RSK2 Activation That Mediates Hematopoietic Transformation. Molecular and Cellular Biology. 29(8). 2105–2117. 50 indexed citations
5.
Kang, Sumin, Shaozhong Dong, Ting-Lei Gu, et al.. (2007). FGFR3 Activates RSK2 to Mediate Hematopoietic Transformation through Tyrosine Phosphorylation of RSK2 and Activation of the MEK/ERK Pathway. Cancer Cell. 12(3). 201–214. 117 indexed citations
6.
Matheny, Christina, Patrick R. Cushing, Yunpeng Zhou, et al.. (2007). Disease mutations in RUNX1 and RUNX2 create nonfunctional, dominant‐negative, or hypomorphic alleles. The EMBO Journal. 26(4). 1163–1175. 85 indexed citations
7.
Gu, Ting-Lei, Thomas Mercher, Jeffrey Tyner, et al.. (2007). A novel fusion of RBM6 to CSF1R in acute megakaryoblastic leukemia. Blood. 110(1). 323–333. 35 indexed citations
8.
Walters, Denise K., Valerie L. Goss, Eric P. Stoffregen, et al.. (2006). Phosphoproteomic analysis of AML cell lines identifies leukemic oncogenes. Leukemia Research. 30(9). 1097–1104. 47 indexed citations
9.
Gu, Ting-Lei, Valerie L. Goss, Cynthia Reeves, et al.. (2006). Phosphotyrosine profiling identifies the KG-1 cell line as a model for the study of FGFR1 fusions in acute myeloid leukemia. Blood. 108(13). 4202–4204. 63 indexed citations
10.
Goetz, Tamara L., Ting-Lei Gu, Nancy A. Speck, & Barbara J. Graves. (2000). Auto-Inhibition of Ets-1 Is Counteracted by DNA Binding Cooperativity with Core-Binding Factor α2. Molecular and Cellular Biology. 20(1). 81–90. 121 indexed citations
11.
Gu, Ting-Lei, Tamara L. Goetz, Barbara J. Graves, & Nancy A. Speck. (2000). Auto-Inhibition and Partner Proteins, Core-Binding Factor β (CBFβ) and Ets-1, Modulate DNA Binding by CBFα2 (AML1). Molecular and Cellular Biology. 20(1). 91–103. 132 indexed citations
12.
Wang, Qing, Terryl Stacy, Ting-Lei Gu, et al.. (1996). The CBFβ Subunit Is Essential for CBFα2 (AML1) Function In Vivo. Cell. 87(4). 697–708. 532 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026